Nakayama, Masato <br/><br/>
Pathological evaluation of uterine leiomyomas treated with gonadotropin-releasing hormone agonist (GnRH-a) therapy: role of mast cells and a possible mechanism of GnRH-a resistance in leiomyomas.  [electronic resource] 

 -  Pathology international  May 2008 
 - 268-74 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1440-1827 
<br/><br/><label>Standard No.: </label>10.1111/j.1440-1827.2008.02222.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Cell Count<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Gonadotropin-Releasing Hormone--agonists<br/>Humans<br/>Insulin-Like Growth Factor I--metabolism<br/>Leiomyoma--drug therapy<br/>Leuprolide--therapeutic use<br/>Mast Cells--drug effects<br/>Premenopause<br/>Uterine Neoplasms--drug therapy